The Addition of Cixutumumab or Temozolomide to Intensive Multiagent Chemotherapy Is Feasible but Does Not Improve Outcome for Patients With Metastatic Rhabdomyosarcoma

Cancer - United States
doi 10.1002/cncr.31770
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2007English

Extended Induction Chemotherapy Does Not Improve the Outcome for High-Risk Neuroblastoma Patients: Results of the Randomized Open-Label GPOH Trial NB2004-HR

Annals of Oncology
MedicineOncologyHematology
2020English

MRP1 but Not MDR1 Is Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2013English

Abdominal CT Does Not Improve Outcome for Children With Suspected Acute Appendicitis

Western Journal of Emergency Medicine
MedicineEmergency Medicine
2015English

Early Decompressive Hemicraniectomy in Older Patients With Nondominant Hemispheric Infarction Does Not Improve Outcome

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2011English

Manual Therapy in Addition to Physiotherapy Does Not Improve Clinical or Economic Outcomes After Ankle Fracture

Journal of Rehabilitation Medicine
MedicinePhysical TherapySports TherapyRehabilitationSports Science
2008English

Addition of Azathioprine to Corticosteroids Does Not Benefit Patients With IgA Nephropathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2010English

Consolidation Radiotherapy Does Not Improve the Outcome as Compared With Chemotherapy Alone in Patients With Limited Stage Diffuse Large B-Cell Lymphoma of Waldeyer's Ring

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

652 Advanced Childhood Rhabdomyosarcoma: Toxicity and Response to Intensive Chemotherapy

Pediatric Research
Child HealthPediatricsPerinatology
1978English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy